"In India, we have agreements with four large manufacturers. India will produce about 300 million doses or more of the vaccine for us next year," he said, Russian news agency Tass reported.

 

Dmitriev noted that out of 110 production sites that negotiated production of Sputnik V, RDIF chose 10 that meet its requirements. "The Russian Sputnik V will be actively produced in the world and we see that this is built on a safe platform based on the human adenovirus," Dmitriev said.

 

Earlier, Dmitriev had said that production of Sputnik V began in other countries, in particular in India, Korea, Brazil and China.